Please login to the form below
New Accounts, February, 2006 - Advertising
The following table lists new pharmaceutical account wins notified to us by the winning agencies for the period November 2005 to January 2006 inclusive
The following table lists new pharmaceutical account wins notified to us by the winning agencies for the period November 2005 to January 2006 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets.
To submit an entry for New Accounts, email nhobson@pmlive.com
|
|
|
|
|
|
BD Medical |
Portfolio |
Regional anaesthesia |
Mason Zimbler |
|
Frontier Medical |
Repose |
Tissue viability |
Mason Zimbler |
|
GlaxoSmithKline (Europe) |
Integrilin |
Cardiovascular |
PAN Advertising |
|
GE Healthcare Discovery Systems |
New product |
N/A |
Seven Stones |
|
Genosis |
Fertell |
Fertility |
Dewar Alexander |
|
Gilead Sciences |
AmBisome |
Antifungal |
FCB Healthcare |
|
GrÈnenthal |
Clarosip |
Antibiotic |
MJL Advertising |
|
Janssen-Cilag Ireland |
Durogesic D-Trans |
Pain relief |
MJL Advertising |
|
Menarini |
Nebilet |
Cardiology |
MJL Advertising |
|
Nutricia Clinical Care |
Glutafin
|
Nutrition |
Life |
|
Organon |
Livial |
HRT |
PAN Advertising |
|
Organon |
Orgaran |
Haematology |
PAN Advertising |
|
Regent Medical |
Website |
Hospital-acquired infections |
The Foundry |
|
Roche |
Tarceva |
Oncology |
MJL Advertising |
|
Schering AG |
Bonefos |
Cancer pain |
Langland |
|
Zeneus Pharma |
N/A |
Systemic fungal infections |
MJL Advertising |
|
Zeon Healthcare |
Krystal Clean Nails |
Nail infections |
LEC |
|
Zeon Healthcare |
ClearZal |
Nail infections |
LEC |
Share
Related Hub content
Subscribe to our email news alerts
- Sanofi and AI specialist Aqemia enter $140m drug discovery partnership
- Novartis’ Fabhalta approved by FDA as first oral monotherapy for rare blood disease PNH
- Merck gains rights to Abbisko’s pimicotinib in deal worth over $70m
- Almirall, BSC and Nostrum Biodiscovery partner for dermatological diseases
- LifeArc launches £5m motor neurone disease drug repurposing programme
- Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
No results were found
PMHub
Say Communications
We focus on what matters most…. Driven by insight, expertise and fresh thinking, our award-winning communications programmes are designed to...
Latest intelligence
- Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
- ...
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
